AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22522414 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular conventional denture or implant overdenture
Number of subjects: 255
Study 20490465 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (0, 12, 25, 50, or 100 mg) with active marijuana (3.27% THC)
Number of subjects: 29
Study 20490465 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (0, 12, 25, 50, or 100 mg) with inactive marijuana (0% THC)
Number of subjects: 29
Study 20490465 — intervention group
Group type: EXPERIMENTAL
Intervention: Active marijuana (3.27% THC)
Number of subjects: 29
Study 20490465 — intervention group
Group type: COMPARATOR
Intervention: Naltrexone alone
Number of subjects: 29
Study 18581595 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised moderate‐intensity exercise therapy for 50 min 3 times per week for 5 weeks
Number of subjects: 40
Study 18581595 — intervention group
Group type: COMPARATOR
Intervention: Self‐shoulder stretching exercise (Control)
Number of subjects: 40
Study 16213286 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting during Ramadan
Number of subjects: 39
Study 16213286 — intervention group
Group type: COMPARATOR
Intervention: Control (non-fasting)
Number of subjects: 39
Study 11815427 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockade of ET(A) and ET(B) receptors using BQ-123 (100 nmol/min) and BQ-788 (50 nmol/min)
Number of subjects: 0
Study 11815427 — intervention group
Group type: COMPARATOR
Intervention: Saline administration
Number of subjects: 0
Study 11815427 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockade of ET(A/B) receptors
Number of subjects: 0
Study 11815427 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP) administration
Number of subjects: 0
Study 11815427 — intervention group
Group type: COMPARATOR
Intervention: ET-1 receptor antagonism
Number of subjects: 0
Study 10525694 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniscus arrow
Number of subjects: 68
Study 10525694 — intervention group
Group type: COMPARATOR
Intervention: Horizontal suture
Number of subjects: 68
Study 10525694 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study 8742454 — intervention group
Group type: EXPERIMENTAL
Intervention: Minute-scale fluctuations in normalized EEG log spectrum
Number of subjects: 0
Study 8742454 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG frequencies during drowsiness
Number of subjects: 0
Study 8742454 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral alertness during drowsiness
Number of subjects: 0
Study 1523288 — intervention group
Group type: EXPERIMENTAL
Intervention: ritanserin (5 mg orally)
Number of subjects: 16
Study 1523288 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 6337285 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/day of elemental calcium)
Number of subjects: 30
Study 6337285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30950743 — intervention group
Group type: EXPERIMENTAL
Intervention: Recline Exercise (RE)
Number of subjects: 22
Study 30950743 — intervention group
Group type: COMPARATOR
Intervention: Head Lift Exercise (HLE)
Number of subjects: 22
Study 30950743 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RE and HLE
Number of subjects: 22
Study 30547799 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (Booklet, Continuous Medical Education (CME), and Pamphlet) in group A (n=38)
Number of subjects: 106
Study 30547799 — intervention group
Group type: EXPERIMENTAL
Intervention: OHC pamphlet in group B (n=32)
Number of subjects: 106
Study 30547799 — intervention group
Group type: COMPARATOR
Intervention: Control group C (n=36)
Number of subjects: 106
Study 27534622 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-only feedback
Number of subjects: 0
Study 27534622 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple stakeholder group feedback
Number of subjects: 0
Study 27534622 — intervention group
Group type: COMPARATOR
Intervention: Multiple feedback
Number of subjects: 0
Study 25095656 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol 0.25 microg/day
Number of subjects: 128
Study 25095656 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol 1 microg/day
Number of subjects: 128
Study 25095656 — intervention group
Group type: COMPARATOR
Intervention: No active vitamin D metabolites (control group)
Number of subjects: 128
Study 22807076 — intervention group
Group type: EXPERIMENTAL
Intervention: DAISY intervention (multifaceted and semi‐tailored counselling, education, and support)
Number of subjects: 330
Study 22807076 — intervention group
Group type: COMPARATOR
Intervention: Control support during follow‐up
Number of subjects: 330
Study 22807076 — intervention group
Group type: EXPERIMENTAL
Intervention: DAISY intervention
Number of subjects: 330
Study 19614687 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbachol (3 µg/kg)
Number of subjects: 18
Study 19614687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 17039266 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cyclophosphamide, methotrexate, fluoracil)
Number of subjects: 401
Study 17039266 — intervention group
Group type: COMPARATOR
Intervention: Control group (low-risk patients not on chemotherapy)
Number of subjects: 401
Study 16313543 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubling daily inhaled corticosteroid (ICS) dose (fluticasone)
Number of subjects: 22
Study 16313543 — intervention group
Group type: COMPARATOR
Intervention: Maintaining usual ICS dose
Number of subjects: 22
Study 16313543 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroids (OS) (dexamethasone)
Number of subjects: 22
Study 12096825 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/DRSP (30 microg ethinyl estradiol / 3 mg drospirenone)
Number of subjects: 128
Study 12096825 — intervention group
Group type: COMPARATOR
Intervention: EE/CPA (35 microg ethinyl estradiol / 2 mg cyproterone acetate)
Number of subjects: 128
Study 12096825 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/DRSP and EE/CPA
Number of subjects: 128
Study 10616770 — intervention group
Group type: EXPERIMENTAL
Intervention: 30mg LA once daily, 500mg AMPC tid, and 250mg MNZ tid for 2 weeks
Number of subjects: 91
Study 10616770 — intervention group
Group type: EXPERIMENTAL
Intervention: 30mg LA bid, 500mg AMPC tid, and 250mg MNZ tid for 2 weeks
Number of subjects: 91
Study 10616770 — intervention group
Group type: EXPERIMENTAL
Intervention: 30mg LA once daily, 500mg AMPC tid, and 250mg MNZ tid for 1 week
Number of subjects: 91
Study 10616770 — intervention group
Group type: EXPERIMENTAL
Intervention: 30mg LA bid, 500mg AMPC tid, and 250mg MNZ tid for 1 week
Number of subjects: 91
Study 8847197 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐like social environment without neuroleptics
Number of subjects: 0
Study 8847197 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital ward treatment with neuroleptic drugs
Number of subjects: 0
Study 1971166 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine administration (2 mg/kg body weight)
Number of subjects: 30
Study 1971166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary propranolol administration (2 mg in 5 minutes)
Number of subjects: 30
Study 1971166 — intervention group
Group type: COMPARATOR
Intervention: Saline administration (control)
Number of subjects: 30
Study 6101847 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 24
Study 6101847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31522896 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted, interactive education program
Number of subjects: 177
Study 31522896 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 177
Study 31331552 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 twirls per minute on ST9
Number of subjects: 120
Study 31331552 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 twirls per minute on ST9
Number of subjects: 120
Study 31331552 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 twirls per minute on LR3
Number of subjects: 120
Study 31331552 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 twirls per minute on LR3
Number of subjects: 120
Study 27653670 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured testing group (STG) measuring 7-points on SMBG for 3 consecutive days once every two months
Number of subjects: 62
Study 27653670 — intervention group
Group type: COMPARATOR
Intervention: Routine testing group (RTG) measuring SMBG 3 times each week before breakfast on Monday and Friday and before dinner on Wednesday
Number of subjects: 62
Study 25350366 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg/day for 7 days, then 10 mg/day for 7 days)
Number of subjects: 24
Study 25350366 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (in participants who gained weight, n=8)
Number of subjects: 24
Study 25350366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 25350366 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (in participants who did not gain weight)
Number of subjects: 24
Study 24332919 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol (0.5 g/kg) plus hydration
Number of subjects: 86
Study 24332919 — intervention group
Group type: COMPARATOR
Intervention: Hydration alone (controls)
Number of subjects: 86
Study 22818406 — intervention group
Group type: EXPERIMENTAL
Intervention: Two physical activity consultations and a 10-week group pram-walking program
Number of subjects: 76
Study 19105621 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor and autologous bone marrow-derived stem/progenitor cells
Number of subjects: 0
Study 19105621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17846129 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHP) treatment
Number of subjects: 598
Study 14691413 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous rotational coronary atherectomy (PRCA)
Number of subjects: 200
Study 14691413 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (PTCA)
Number of subjects: 200
Study 14691413 — intervention group
Group type: EXPERIMENTAL
Intervention: PRCA
Number of subjects: 200
Study 14691413 — intervention group
Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 200
Study 11773913 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy
Number of subjects: 7081
Study 9834564 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates of mothers with pregnancy induced hypertension (PIH)
Number of subjects: 30
Study 9834564 — intervention group
Group type: COMPARATOR
Intervention: Neonates born to normotensive mothers
Number of subjects: 30
Study 7859451 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu 380A IUD
Number of subjects: 0
Study 7859451 — intervention group
Group type: COMPARATOR
Intervention: TCu 220C IUD
Number of subjects: 0
Study 2645490 — intervention group
Group type: EXPERIMENTAL
Intervention: Shepard Teflon grommet
Number of subjects: 0
Study 2645490 — intervention group
Group type: EXPERIMENTAL
Intervention: Armstrong beveled tube
Number of subjects: 0
Study 2645490 — intervention group
Group type: EXPERIMENTAL
Intervention: Reuter‐Bobbin tube
Number of subjects: 0
Study 2645490 — intervention group
Group type: EXPERIMENTAL
Intervention: Goode T‐tube
Number of subjects: 0
Study 945688 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen erythrocytes diluted in plasma
Number of subjects: 43
Study 945688 — intervention group
Group type: COMPARATOR
Intervention: Whole blood less than 5 days old
Number of subjects: 43
Study 31418804 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Preauthorization (PA)
Number of subjects: 2692
Study 31418804 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprescription Audit and Review (PPR)
Number of subjects: 2692
Study 28448502 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples counseling training
Number of subjects: 808
Study 28448502 — intervention group
Group type: COMPARATOR
Intervention: No couples counseling training (Control)
Number of subjects: 808
Study 25597438 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oxycodone and pregabalin (B1 group)
Number of subjects: 300
Study 25597438 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oxycodone and pregabalin (B2 group)
Number of subjects: 300
Study 25597438 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (A1 group)
Number of subjects: 300
Study 25597438 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (A2 group)
Number of subjects: 300
Study 23103352 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) and strontium-89 (Sr-89) simultaneously (Group A)
Number of subjects: 180
Study 23103352 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) alone (Group B)
Number of subjects: 180
Study 23103352 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89 (Sr-89) alone (Group C)
Number of subjects: 180
Study 23103352 — intervention group
Group type: COMPARATOR
Intervention: Untreated (Group D)
Number of subjects: 180
Study 21756432 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltreated Intervention (MI) group (combined child-parent psychotherapy and psychoeducational parenting intervention)
Number of subjects: 91
Study 21756432 — intervention group
Group type: COMPARATOR
Intervention: Control group (CS)
Number of subjects: 91
Study 21756432 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmaltreated Comparison (NC) group
Number of subjects: 91
Study 19936416 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (Group D, n=42)
Number of subjects: 81
Study 19936416 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride infusion (Group P, n=39)
Number of subjects: 81
Study 17007855 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse‐transcription‐polymerase chain reaction (RT‐PCR) analysis of HSPA2 gene expression in adolescents with varicocele and oligozoospermia
Number of subjects: 2
Study 17007855 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse‐transcription‐polymerase chain reaction (RT‐PCR) analysis of HSPA2 gene expression in adolescents with varicocele and normal sperm concentration
Number of subjects: 2
Study 17007855 — intervention group
Group type: COMPARATOR
Intervention: Reverse‐transcription‐polymerase chain reaction (RT‐PCR) analysis of HSPA2 gene expression in adolescents without varicocele (controls)
Number of subjects: 2
Study 15609737 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-item depression screen
Number of subjects: 1211
Study 15609737 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-2 score > or =3
Number of subjects: 1211
Study 15609737 — intervention group
Group type: COMPARATOR
Intervention: PHQ-9
Number of subjects: 1211
Study 15609737 — intervention group
Group type: COMPARATOR
Intervention: PHQ-9 item assessing thoughts of death or suicide
Number of subjects: 1211
Study 15609737 — intervention group
Group type: COMPARATOR
Intervention: PHQ-8
Number of subjects: 1211
Study 15609737 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-2
Number of subjects: 1211
Study 11286309 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA and dalteparin for 4 to 7 days
Number of subjects: 0
Study 11286309 — intervention group
Group type: COMPARATOR
Intervention: rt-PA and UFH for 48 hours
Number of subjects: 0
Study 9308804 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (measured by follicular fluid concentrations of cotinine)
Number of subjects: 234
Study 8100289 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 14
Study 8100289 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 14
Study 3429697 — intervention group
Group type: COMPARATOR
Intervention: 10 mg nifedipine, sublingually administered
Number of subjects: 16
Study 3429697 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic oral nifedipine, 10 mg qid
Number of subjects: 16
Study 29679670 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention (MBRP) combined with virtual reality cue exposure (VRCE) for 8 weeks
Number of subjects: 180
Study 29679670 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based relapse prevention (MBRP) alone for 8 weeks
Number of subjects: 180
Study 29679670 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual for 8 weeks
Number of subjects: 180
Study 27164462 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil
Number of subjects: 163
Study 27164462 — intervention group
Group type: COMPARATOR
Intervention: Comparator (vancomycin or cefazolin, plus optional aztreonam)
Number of subjects: 163
Study 27164462 — intervention group
Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 163
Study 24553807 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based intervention (skin self-examination and skin awareness)
Number of subjects: 870
Study 24553807 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based intervention
Number of subjects: 870
Study 24553807 — intervention group
Group type: COMPARATOR
Intervention: Control group (brochures only)
Number of subjects: 870
Study 22545424 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lornoxicam (8 mg)
Number of subjects: 60
Study 22545424 — intervention group
Group type: COMPARATOR
Intervention: Oral paracetamol (500 mg)
Number of subjects: 60
Study 22545424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (lornoxicam and paracetamol)
Number of subjects: 60
Study 19517165 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 160
Study 19517165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 160
Study 19517165 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 160
Study 18450380 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI(2)) infusion at 10 ng/kg/min for 25 min
Number of subjects: 12
Study 18450380 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study 18450380 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI(2)) infusion
Number of subjects: 12
Study 16835477 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen (CPT‐11 180 mg/m(2) as a 90‐min infusion on day 1, l‐LV 200 mg/m(2) as a 2‐h infusion during CPT‐11, followed by a bolus dose of 5‐FU 400 mg/m(2) and a 46‐h continuous infusion of 2,400 mg/m(2) every 2 weeks)
Number of subjects: 0
Study 16835477 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen
Number of subjects: 0
Study 16835477 — intervention group
Group type: EXPERIMENTAL
Intervention: oxaliplatin/5‐FU/LV therapy (FOLFOX)
Number of subjects: 0
Study 15342678 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 65
Study 15342678 — intervention group
Group type: COMPARATOR
Intervention: High-MUFA diet
Number of subjects: 65
Study 11737921 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-operative pulmonary-artery catheter use
Number of subjects: 0
Study 11737921 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated protein C and low-dose steroids in sepsis
Number of subjects: 0
Study 11737921 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0
Study 11737921 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based guidelines for the prevention of ventilator-acquired pneumonia
Number of subjects: 0
Study 11737921 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical errors in the critical care unit
Number of subjects: 0
Study 9148012 — intervention group
Group type: EXPERIMENTAL
Intervention: 1992 study
Number of subjects: 31
Study 9148012 — intervention group
Group type: COMPARATOR
Intervention: 1987 study
Number of subjects: 31
Study 8442393 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dipyridamole 75 mg and acetylsalicylic acid 330 mg t.i.d.
Number of subjects: 2500
Study 8442393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2500
Study 2945040 — intervention group
Group type: EXPERIMENTAL
Intervention: 42 micrograms HBsAg for each vaccination (Group A)
Number of subjects: 217
Study 2945040 — intervention group
Group type: COMPARATOR
Intervention: 84 micrograms for the first and 21 micrograms for the second and third vaccinations (Group B)
Number of subjects: 217
Study 2945040 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourth vaccination for non-responders and low-responders (n=40)
Number of subjects: 217
Study 2945040 — intervention group
Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 217
Study 2945040 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of participants
Number of subjects: 217
Study 31347611 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepirone extended-release tablets (gepirone ER, Travivo)
Number of subjects: 0
Study 31347611 — intervention group
Group type: COMPARATOR
Intervention: Gepirone
Number of subjects: 0
Study 29974972 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (target breath alcohol level 0.080%)
Number of subjects: 62
Study 29974972 — intervention group
Group type: COMPARATOR
Intervention: No alcohol (control group)
Number of subjects: 62
Study 27795670 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg intravenous dexamethasone (DM group)
Number of subjects: 78
Study 27795670 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (NS group)
Number of subjects: 78
Study 27795670 — intervention group
Group type: EXPERIMENTAL
Intervention: DM group
Number of subjects: 78
Study 27795670 — intervention group
Group type: COMPARATOR
Intervention: NS group
Number of subjects: 78
Study 24413969 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIT maintenance treatment (MT)
Number of subjects: 61
Study 24413969 — intervention group
Group type: COMPARATOR
Intervention: Assessment‐only follow‐up condition (AO)
Number of subjects: 61
Study 22791229 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued location (valid cue)
Number of subjects: 0
Study 22791229 — intervention group
Group type: COMPARATOR
Intervention: Uncued location (invalid cue)
Number of subjects: 0
Study 22791229 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral results with 1,000 ms SOA
Number of subjects: 0
Study 22791229 — intervention group
Group type: EXPERIMENTAL
Intervention: N2pc amplitudes across cue types
Number of subjects: 0